EULAR® 2024 Insights

 

EULAR® 2024 Insights
M

Clinical features of patients with SpA, with or without IBD: results from the METEOR cohort

By EULAR® 2024 Insights FEATURING Manouk De Hooge
By EULAR® 2024 Insights FEATURING Manouk De Hooge
10 views
July 24, 2024
Comments 0
Login to view comments. Click here to Login
Spondyloarthropathies
20:07

Highlights of EULAR 2024 in Spondyloarthritis and Psoriatic Arthritis

EULAR® 2024 Insights

K. Aouad

270 views
09:51

Clinical features of patients with SpA, with or without IBD: results…

EULAR® 2024 Insights

M. De Hooge

10 views
08:34

EULAR® 2024 Insights- Reasons for Non-response to Treatments in Pati…

EULAR® 2024 Insights

F. Coşan

8 views
09:55

EULAR® 2024 Insights: Reasons for Non-response to Treatments in Pati…

EULAR® 2024 Insights

F. Coşan

61 views
06:35

EULAR® 2024 Insights: Impact of Peripheral Arthritis on Disease Acti…

EULAR® 2024 Insights

C. Lopez-Medina

11:13

EULAR® 2024 Insights: Apremilast Treatment in Early Oligoarticular P…

EULAR® 2024 Insights

L. Gossec

14 views
05:42

EULAR® 2024 Insights: Associations Between Clinical Characteristics …

EULAR® 2024 Insights

E. R. Soriano

04:06

EULAR® 2024 Insights - Factors Associated with the Evolution of Dege…

EULAR® 2024 Insights

L. Pina Vegas

38 views
05:43

EULAR® 2024 Insights: Chronic Kidney Disease in Patients with Psoria…

EULAR® 2024 Insights

D. Gladman

65 views
04:54

EULAR® 2024 Insights: Guselkumab Provides Durable Improvements in Pa…

EULAR® 2024 Insights

L. Coates

48 views
33:05

EULAR® 2024 Insights: Spot on Treatment Failure in PsA: Where Are th…

EULAR® 2024 Insights

V. Chandran

104 views
09:15

EULAR® 2024 Insights - Sex-Related Differences in Trial Outcomes in …

EULAR® 2024 Insights

L. Eder

52 views
04:46

EULAR® 2024 Insights: Drug Survival of First-line TNF and Apremilast…

EULAR® 2024 Insights

A. Ogdie

80 views
07:39

EULAR® 2024 Insights - Enhancing the Diagnostic Accuracy and Avoidin…

EULAR® 2024 Insights

D. Poddubnyy

99 views